Switch View
© PR Newswire
23.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Savara Inc. ("Savara" or "the Company") (NASDAQ: SVRA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promul...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Semler Scientific, Inc. ("Semler" or "the Company") (NASDAQ: SMLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SMLR
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Semler Scientific, Inc. ("Semler " or "the Company") (NASDAQ: SMLR ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Secu...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Newsfile
23.10.2025
ISIN: CA24463V1013
Defence Therapeutics Inc.
DTC
LISTED
CSE
Defence to Present New Scientific Data on Its ADC-Enhancing Accum Technology at the World ADC Conference in San Diego, USA, November 4-5, 2025
News Preview
Montreal, Quebec--(Newsfile Corp. - October 23, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company specialized in drug delivery technologies, is pleased to announce that it will present new scientific data highlighting the performance of its Accum® technolo...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
23.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against LifeMD, Inc. ("LifeMD " or "the Company") (NASDAQ: LFMD ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against LifeMD, Inc. ("LifeMD" or "the Company") (NASDAQ: LFMD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promu...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2025
ISIN: US9174881089
Utah Medical Products Inc
UTMD
LISTED
NASDAQ
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025
News Preview
SALT LAKE CITY, UT / ACCESS Newswire / October 23, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2025 financial results that were unusually hampered by global trade uncertainty.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 23, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) be...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: SE0011205202
Vitrolife AB
VITR
LISTED
STO
Vitrolife AB (publ) - Interim report Q3, 2025: Strong growth in Americas
News Preview
GOTHENBURG, Sweden, Oct. 23, 2025 /PRNewswire/ --
Third quarter
Sales of SEK 835 (867) million, 3% growth in local currencies and a 4% decrease in SEK, due to a significant currency impact of -7%. Organic growth in local curren...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2025
ISIN: US87975F1049
Telomir Pharmaceuticals, Inc.
TELO
LISTED
NASDAQ
Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer's “Kill-and-Clean” Defense Systems in an Aggressive Prostate Cancer Model, Outperforming Rapamycin and Chemo
News Preview
New findings highlight Telomir-1's impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer. MIAMI, FLORIDA / ACCESS Newswire / October 23, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical biotechn...
Themefolio
Profiler
Peergroup
© Newsfile
23.10.2025
ISIN: CH1176493729
Bachem Holding AG
BANB
LISTED
SIX
Bachem Announces Progress in Building K Start-Up and Expansion of Its Site in Vista, CA
News Preview
The capacity expansion in Bubendorf reached another important milestone with the inspection of Building K. The announced start-up is proceeding according to plan. In Vista, CA, Bachem acquired a property adjacent to its existing facility. The acquisition will enable a future capacity expansion at the Vista site, thereby strengtheni...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2025
ISIN: US60770K1079
Moderna, Inc
MRNA
LISTED
NASDAQ
Moderna to Host Investor Event - Analyst Day
News Preview
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025.The event will include presentations from management discussing Moderna's development and commercial strategy and key business considerations.A live webcas...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
23.10.2025
ISIN: CH1335392721
Galderma Group AG
GALD
LISTED
XWSX
Galderma Delivers Record Net Sales of 3.737 Billion USD in the First Nine Months of 2025 and 15.0% Year-on-Year Growth at Constant Currency, Raises Full-Year Guidance
News Preview
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the first nine months of 2025, delivering record net sales along with strong commercial and innovation momentum across its portfolio.
Record net sales of 3.737 billion USD for the first nine months of the year, representing net sal...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.10.2025
ISIN: CH0360674466
Galenica AG
GALE
LISTED
SIX
Galenica bleibt auf Wachstumskurs
News Preview
MedienmitteilungAd hoc-Mitteilung gemäss Art. 53 KR
Der Umsatz der Galenica Gruppe ist bis zum dritten Quartal 2025 um 4.7% auf CHF 2'999.7 Mio. gewachsen.
Treiber für das Umsatzwachstum sind rezeptpflichtige Medikamente und Nahrungsergänzungsmittel.
Durch die Akquisition von Labor Team erwartet Galenica neu ein Umsatzwachstum zwischen 4% und 6% ......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.10.2025
ISIN: CH0360674466
Galenica AG
GALE
LISTED
SIX
Galenica remains on growth track
News Preview
Press releaseAd hoc announcement pursuant to Art. 53 LR
Galenica Group sales grew 4.7% to CHF 2,999.7 million in the third quarter of 2025.
Sales growth is driven by prescription drugs and dietary supplements.
Thanks to the acquisition of Labor Team, Galenica now expects sales growth of between 4% and 6% and an increase in EBIT1 of between 10% an......
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: IT0003828271
Recordati Industria Chimica e Farmaceutica SpA
REC
LISTED
EURONEXT
RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER
News Preview
NEWS RELEASE...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.10.2025
ISIN: CH0013841017
Lonza Group AG
LONN
LISTED
SIX
Lonza Delivers a Strong Q3 2025 and Confirms Full-Year 2025 Outlook for its CDMO and CHI Businesses
News Preview
Ad hoc announcement pursuant to Art. 53 LR
Strong CDMO1 performance in Q3 2025 in Integrated Biologics and Advanced Synthesis, while Specialized Modalities improved versus a soft H1
Large contract signings in Q3, including another significant commercial contract for Vacaville
Capsules & Health Ingredients (CHI) returned to growth as expected ......
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Changes to the Roche Enlarged Corporate Executive Committee
News Preview
Basel, 23 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Nina Schwab-Hautzinger (1975) has been appointed Head of Group Communications and a member of the enlarged Corporate Executive Committee effective 1 February 2026....
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
BAX INVESTORS: Kirby McInerney LLP Reminds Baxter International, Inc. Investors of Important Deadline in Class Action Lawsuit
News Preview
If you have suffered a loss on your Baxter International, Inc. (“Baxter” or the “Company”) (NYSE:BAX) investment, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
Investors have until...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Securities Fraud Investigation Into Baxter International, Inc. (BAX) Announced – Shareholders Who Lost Money Urged to Contact the Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON BAXTER INTERNATIONAL, INC. (BAX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUI...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US0311621009
Amgen Inc
AMGN
LISTED
NASDAQ
Halper Sadeh LLC Encourages Amgen Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Amgen Inc. (NASDAQ: AMGN) breached their fiduciary duties to shareholders.
If you currently own Amgen stock and acquired shares on or before July 29, 2020, you may be able to seek corporate governance reforms, the return of funds back to the...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Molina Healthcare, Inc. (MOH) Investors: December 2, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
News Preview
RADNOR, Pa., Oct. 22, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Molina Healthcare, Inc. ("Molina") (NYSE: MOH) on behalf of those who purchased or otherwise acquired Molina securities...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
ISIN: US09075A1088
Bioventus Inc
BVS
LISTED
NASDAQ
Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Bioventus Inc. (NASDAQ: BVS) breached their fiduciary duties to shareholders.
If you currently own Bioventus stock and acquired shares on or before February 11, 2021, you may be able to seek corporate governance reforms, the return of funds...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US28176E1082
Edwards Lifesciences Corp.
EW
LISTED
NYSE
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation - EW
News Preview
NEW YORK, Oct. 22, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Edwards Lifesciences Corporation (NYSE: EW)....
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH Investors Have Opportunity to Lead Molina Healthcare, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 22, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Molina Healthcare, Inc. (NYSE...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
ISIN: KYG4672N1198
HUTCHMED (China) Ltd
13
LISTED
HKSE
HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
News Preview
— First investigational drug candidate using the HUTCHMED ATTC technology platform to create potent targeted therapy payloads while mitigating related toxicities —...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US05337M1045
Avadel Pharmaceuticals plc
AVDL
LISTED
NASDAQ
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL)
News Preview
NEW YORK, Oct. 22, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquarte...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: CA05156X8504
Aurora Cannabis Inc
ACB
LISTED
NASDAQ
Aurora Cannabis to Host Second Quarter 2026 Investor Conference Call
News Preview
NASDAQ | TSX: ACB
EDMONTON, AB, Oct. 22, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its second quarter 2026 on...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: CA05156X8504
Aurora Cannabis Inc
ACB
LISTED
NASDAQ
Aurora Cannabis to Host Second Quarter 2026 Investor Conference Call
News Preview
NASDAQ | TSX: ACB
EDMONTON, AB, Oct. 22, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its second quarter...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US4364401012
Hologic Inc
HOLX
LISTED
NASDAQ
Hologic Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX
News Preview
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Hologic, Inc. (NasdaqGS: HOLX) to funds managed by Blackstone and TPG. Under the terms of the proposed transaction, shareholders of Hologic will receive $76.00 per share in cash plus a non-tr...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US05337M1045
Avadel Pharmaceuticals plc
AVDL
LISTED
NASDAQ
Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plc - AVDL
News Preview
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avadel Pharmaceuticals plc (NasdaqGM: AVDL) to Alkermes plc (NasdaqGS: ALKS). Under the terms of the proposed transaction, shareholders of Avadel will receive $18.50 per share, plus a non-tra...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference
News Preview
Johnson & Johnson (NYSE: JNJ) will present at the 7th Annual Wolfe Research Healthcare Conference on Monday, November 17th, 2025. Management will participate in a Fireside Chat at 10:40 a.m. Eastern Time.
A live audio webcast of the presentation will be accessible through Johnson & Johnson’s Investor Relations website at www.investor.jnj...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US9216591084
Vanda Pharmaceuticals Inc
VNDA
LISTED
NASDAQ
Vanda Pharmaceuticals to Announce Third Quarter 2025 Financial Results on October 29, 2025
News Preview
Conference Call and Webcast to Follow
WASHINGTON, Oct. 22, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2025 on Wednesday, October 29, 2025, after the market closes....
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US1255091092
Cigna Group (The)
CI
LISTED
NYSE
The Cigna Group Declares Quarterly Dividend
News Preview
BLOOMFIELD, Conn., Oct. 22, 2025 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.51 per share of its common stock, payable on December 18, 2025 to shareholders of record as of the close of business on December 4, 2025....
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
ICON Reports Third Quarter 2025 Results
News Preview
ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today reported its financial results for the third quarter ended September 30, 2025.
CEO, Mr. Barry Balfe commented, “ICON’s results in quarter three were reflective of broad market conditions, as we continued to partner with customers to navigate an uncertain environment....
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US45784A1043
InnovAge Holding Corp
INNV
LISTED
NASDAQ
Halper Sadeh LLC Encourages InnovAge Holding Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of InnovAge Holding Inc. (NASDAQ: INNV) breached their fiduciary duties to shareholders.
If you currently own InnovAge stock and acquired shares on or before March 4, 2021, you may be able to seek corporate governance reforms, the return of fun...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: IE00B4Q5ZN47
Jazz Pharmaceuticals PLC
JAZZ
LISTED
NASDAQ
Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 5, 2025
News Preview
DUBLIN, Oct. 22, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2025 third quarter financial results on Wednesday, November 5, 2025, after the close of the U.S. financial markets. Company management will host a live audio webcast at 4:30 p.m. EST / 9:30 p.m. G...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US1124631045
Brookdale Senior Living Inc
BKD
LISTED
NYSE
Brookdale Announces Third Quarter 2025 Earnings Release and Conference Call Dates
News Preview
BRENTWOOD, Tenn., Oct. 22, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) will release its third quarter 2025 financial results after the close of the market on Thursday, November 6, 2025. In conjunction with this release, the Company will hold a conference call on Friday, November 7, 2025, at 8:00...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: IE00B4Q5ZN47
Jazz Pharmaceuticals PLC
JAZZ
LISTED
NASDAQ
Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 5, 2025
News Preview
DUBLIN, Oct. 22, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2025 third quarter financial results on Wednesday, November 5, 2025, after the close of the U.S. financial markets. Company management will host a live audio webcast at 4:30 p.m. EST / 9:30 p.m. G...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Molina Healthcare Reports Third Quarter 2025 Financial Results
News Preview
Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported third quarter 2025 GAAP earnings per diluted share of $1.51 and adjusted earnings per diluted share of $1.84. Financial results are summarized below:
Three months ended
Nine months ended
September 30,
September 30,
...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US58506Q1094
Medpace Holdings Inc
MEDP
LISTED
NASDAQ
Medpace Holdings, Inc. Reports Third Quarter 2025 Results
News Preview
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2025.
Third Quarter 2025 Financial Results
Revenue for the three months ended September 30, 2025 increased 23.7% to $659.9 million, compared to $533.3 million for the comparable prior-year period. On a constant currency...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US92686J1060
Viking Therapeutics Inc
VKTX
LISTED
NASDAQ
Viking Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
Conference call scheduled for 4:30 p.m. ET today
Phase 3 VANQUISH Trials for Subcutaneous VK2735 in Obesity Proceeding on Schedule
VK2735 Phase 1 Maintenance Dosing Study Underway...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US09061G1013
BioMarin Pharmaceutical Inc
BMRN
LISTED
NASDAQ
BioMarin to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Monday, October 27, 2025, at 4:30pm ET
News Preview
SAN RAFAEL, Calif., Oct. 22, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Monday, October 27, 2025, at 4:30 p.m. ET to discuss third quarter 2025 financial result...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US0906831039
Biote Corp
BTMD
LISTED
NASDAQ
Biote Schedules Third Quarter 2025 Financial Results Release and Conference Call
News Preview
biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide third quarter financial results on Wednesday, November 5, 2025, after the close of the market. A conference call t...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US1167941087
Bruker Corp
BRKR
LISTED
NASDAQ
Bruker Announces Date and Time of Third Quarter 2025 Earnings Release and Webcast
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2025 financial results before market opening on Monday, November 3, 2025. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends.
To listen to the webcast, investors can go to https://ir.bruker....
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US92764N1028
Vir Biotechnology Inc
VIR
LISTED
NASDAQ
Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that the Company will provide a corporate update and report financial results for the third quarter ended September 30, 2025, on November 5, 2025. The Company will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET on November 5, 2025.
The corporate update and financial results will be pr...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US74587B1017
Pulse Biosciences Inc
PLSE
LISTED
NASDAQ
Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced it will report business updates and financial results for the third quarter 2025 after market close on Wednesday, November 5, 2025. Company management w...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US14817C1071
Cassava Sciences Inc
SAVA
LISTED
NASDAQ
Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Cassava Sciences, Inc. (NASDAQ: SAVA) breached their fiduciary duties to shareholders.
If you currently own Cassava stock and acquired shares on or before September 14, 2020, you may be able to seek corporate governance reforms, the return o...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US7599101026
KORU Medical Systems Inc
KRMD
LISTED
NASDAQ
KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025
News Preview
KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report third quarter 2025 financial results on Wednesday...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US21900C3088
CorMedix Inc
CRMD
LISTED
NASDAQ
Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of CorMedix Inc. (NASDAQ: CRMD) breached their fiduciary duties to shareholders.
If you currently own CorMedix stock and acquired shares on or before October 16, 2019, you may be able to seek corporate governance reforms, the return of funds ba...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US2681582019
Dynavax Technologies Corp
DVAX
LISTED
NASDAQ
Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025
News Preview
EMERYVILLE, Calif., Oct. 22, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report third quarter 2025 financial results on Wednesday, November 5, 2025, after the U.S. financial markets clos...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US45720N1037
Inhibrx Biosciences Inc
INBX
LISTED
NASDAQ
Inhibrx To Host Webcast Presentation of Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and to Provide Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
News Preview
– Event to be webcast live on Thursday, October 23, 2025 at 1:30 p.m. PT –
SAN DIEGO, Oct. 22, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeuti...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US14167L1035
CareDx Inc
CDNA
LISTED
NASDAQ
CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors
News Preview
CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced the appointment of Suresh Gunasekaran to its Board of Directors.
Suresh currently serves as President and Chief Execu...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US56600D1072
Maravai LifeSciences Holdings Inc
MRVI
LISTED
NASDAQ
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025
News Preview
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2025 financial and operating results after the market close on Thursday, November 6, 2025, and will host a conference call and webcast on the same day at 2:00 p.m. P...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain
News Preview
MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that it has dosed the first patient in a Phase 1 clinical trial of TLX090 (153Samarium (Sm)-DOTMP), a therapeutic radiopharmaceutical candidate for treating pain asso...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US0042251084
ACADIA Pharmaceuticals Inc
ACAD
LISTED
NASDAQ
Halper Sadeh LLC Encourages Acadia Pharmaceuticals Inc. Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) breached their fiduciary duties to shareholders.
If you currently own Acadia stock and acquired shares on or before September 9, 2019, you may be able to seek corporate governance reforms, the retur...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: CA75150G1046
Ramm Pharma Corp.
RAMM
LISTED
CSE
RAMM Pharma Corp. Provides Update on Canada post strike and mailing of the Company´s meeting materials
News Preview
TORONTO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), wishes to notify shareholders that a disruption due to the ongoing Canada Post strike (the “Postal Strike”), and the recent update that mail will resume partial service, but there may still be delays, the Co...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 22, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. (LNTH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 22, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US68236X1000
Oncology Institute Inc
TOI
LISTED
NASDAQ
The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call
News Preview
CERRITOS, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that the company will release its third quarter 2025 financial results after the market close on Thursday, November 13, 2025, to be followed by a conference call the same day at...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
